SLNO
Soleno Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.76B
P/E Ratio
27.47
EPS
$1.93
Beta
-2.22
52W High
$90.32
52W Low
$29.43
50-Day MA
$45.78
200-Day MA
$51.16
Dividend Yield
—
Profit Margin
33.70%
Forward P/E
13.12
PEG Ratio
0.00
About Soleno Therapeutics Inc
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of rare diseases. The company is headquartered in Redwood City, California.
Fundamentals
| Revenue (TTM) | $285.01M |
| Gross Profit (TTM) | $281.11M |
| EBITDA | $91.52M |
| Operating Margin | 33.60% |
| Return on Equity | 26.40% |
| Return on Assets | 12.10% |
| Revenue/Share (TTM) | $5.45 |
| Book Value | $8.61 |
| Price-to-Book | 5.57 |
| Price-to-Sales (TTM) | 9.69 |
| EV/Revenue | 8.99 |
| EV/EBITDA | 23.94 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $52.12M |
| Float | $51.45M |
| % Insiders | 1.31% |
| % Institutions | 111.53% |
Historical Volatility
HV 10-Day
0.48%
HV 20-Day
1.13%
HV 30-Day
2.26%
HV 60-Day
74.94%
HV Rank
0.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($53.00 target)
11
HoldMore HEALTHCARE Stocks
Data last updated: 5/23/2026